USA Financial Formulas’s Bioventus BVS Stock Holding History

USA Financial Formulas’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$42K	Buy	+3,079	New	+$40.6K	0.01%	252

Other funds holding BVS

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return

Kestra Private Wealth Services Austin, Texas $9.37B AUM 22.72% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Seizert Capital Partners Birmingham, Michigan $2.3B AUM 16.06% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

USA Financial Formulas's BVS Position: Q3 2026 in Review

USA Financial Formulas opened a new position in Bioventus (BVS) in Q3 2026: 3,079 shares worth $42K. The stake represents 0.01% of the portfolio and ranks #252 among its holdings.

35 funds tracked by Wall St. Rank hold BVS as of Q3 2026.

USA Financial Formulas held 3,079 shares of Bioventus worth $42K as of Q3 2026.
Bioventus was a new USA Financial Formulas position in Q3 2026.
Bioventus made up 0.01% of USA Financial Formulas's portfolio in Q3 2026, its #252 holding.
35 funds tracked by Wall St. Rank held Bioventus as of Q3 2026.

Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.